
Topic
Medicare Part D
Part D formulary design, IRA negotiated prices, out-of-pocket caps, LIS/Extra Help, and Medicare drug coverage policy.

Pricing & Access· June 6, 2026 · 10 min read
By Ran Chen#GLP-1#Pharmacy Benefit#Medical Benefit

Pricing & Access· June 6, 2026 · 12 min read
Humana GLP-1 coverage: PA criteria, formulary tiers, and 2026 plan rules
By Ran Chen#GLP-1#Prior Authorization#Payer Coverage

Pricing & Access· June 6, 2026 · 12 min read
Medicare Part D GLP-1 coverage 2026: Bridge program, $2,100 cap, and indications
By Ran Chen#GLP-1#Medicare Part D#Prior Authorization

Pricing & Access· June 5, 2026 · 15 min read
Rybelsus coverage guide: oral semaglutide access, formulary tiers, and prior authorization
By Ran Chen#GLP-1#Payer Coverage#Prior Authorization

Policy· June 4, 2026 · 13 min read
Medicare Part D GLP-1 coverage policy and the 2026 Bridge
By Ran Chen#GLP-1#Medicare Part D#Payer Coverage

Pricing & Access· June 4, 2026 · 13 min read
Ozempic prior authorization checklist for 2026
By Ran Chen#GLP-1#Prior Authorization#Payer Coverage

Pricing & Access· June 4, 2026 · 14 min read
TNF inhibitor access landscape: Humira, Enbrel, Remicade, Cimzia, and Simponi in 2026
By Ran Chen#Biosimilars#TNF Inhibitor#Payer Coverage

Pricing & Access· May 31, 2026 · 13 min read
GLP-1 reauthorization after BMI drops below the original threshold
By Ran Chen#GLP-1#Prior Authorization#Medicare Part D

Pricing & Access· May 31, 2026 · 9 min read
IRA MFP formulary inclusion exception: successor products and plan design

Pricing & Access· May 31, 2026 · 15 min read
Medicare GLP-1 Bridge PA evidence file and documentation
By Ran Chen#GLP-1#Medicare Part D#Prior Authorization